Janux Therapeutics (JANX) Interest Expenses (2020)
Janux Therapeutics (JANX) reported Interest Expenses of $109000.0 for Q2 2020.
Janux Therapeutics (JANX) Interest Expenses (2020) Analysis & Trends
Janux Therapeutics (JANX) has 1 years of Interest Expenses data on file, last reported at $109000.0 in Q2 2020.
- Interest Expenses for Q2 2020 came in at $109000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $109000.0 (changed N/A YoY), and the FY2020 annual result was $206000.0, changed N/A from the prior year.
- Interest Expenses steadied at $109000.0 in Q2 2020 per JANX's latest filing.
- Over five years, Interest Expenses peaked at $109000.0 in Q2 2020 and troughed at $109000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Janux Therapeutics | 892.99 Mn | 892.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 109,000.00 |
| Jun 30, 2020 | 109,000.00 |